Status:

COMPLETED

SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue

Lead Sponsor:

SonoClear AS

Conditions:

Brain Tumour

High Grade Glioma

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The objective of this clinical investigation is to assess the safety and performance of the SonoClear Acoustic Coupling Fluid (ACF). The performance will be assessed by analysis of the contrast-to-noi...

Detailed Description

Ultrasound images will be obtained at different timepoints during the operation. First timepoint being after craniotomy (no fluids involved). Second timepoint being when some tumour is left in the bot...

Eligibility Criteria

Inclusion

  • A diffuse malignant glial tumour (high (grade III and IV) or low grade (grade I-II) is suspected from the diagnostic MRI scan
  • A tumour that extends at least 3 cm in depth from the surface of the brain (confirmed by MRI)
  • Pre- or peri-procedural confirmed histopathology of glioma
  • ≥18 years of age
  • Karnofsky performance status ≥ 70
  • Life expectancy of more than 30 days at the time of the procedure
  • Negative pregnancy test for female subjects of childbearing potential

Exclusion

  • Not able to give consent (e.g. severe cognitive impairment)
  • History of brain radiation therapy
  • Recent meningitis (within 6 months prior to screening visit)
  • Other active infection (within 30 days prior to screening visit)
  • Immuno-incompetent patient (e.g. failing immune system due to AIDS)
  • Patients taking immune-suppressive medication
  • Intended biopsy only (meaning: cases not suitable for resection)
  • Known hypersensitivity to egg protein
  • Known hypersensitivity to soybean or peanut protein
  • Known Hypersensitivity to glycerol
  • Known Hypersensitivity to polysorbates
  • Pregnant or lactating females or females who intend to become pregnant during the time of the study

Key Trial Info

Start Date :

September 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2024

Estimated Enrollment :

45 Patients enrolled

Trial Details

Trial ID

NCT04734444

Start Date

September 1 2021

End Date

December 31 2024

Last Update

June 17 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Universitätsklinikum Ulm

Günzburg, Germany, 89312

2

Philipps-Universität Marburg

Marburg, Germany, 35037

3

Instituto Neurologico "C. Besta"

Milan, Italy, 20133

4

University Hospital Bratislava

Bratislava, Slovakia, 83305